BPSR - Organicell Regenerative Medicine, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0350
+0.0020 (+6.06%)
At close: 12:54PM EDT
Stock chart is not supported by your current browser
Previous Close0.0330
Open0.0370
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0300 - 0.0370
52 Week Range0.0040 - 0.1000
Volume161,000
Avg. Volume138,541
Market Cap15.13M
Beta (3Y Monthly)8.41
PE Ratio (TTM)N/A
EPS (TTM)-0.0830
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire3 months ago

    Organicell Welcomes Dr. George C. Shapiro To The Medical Advisory Board

    BOCA RATON, Fla., Feb. 25, 2019 /PRNewswire/ -- Biotech Products Services and Research, Inc. operating as Organicell Regenerative Medicine Inc. (BPSR), today announced the appointment of George C. Shapiro, M.D. F.A.C.C. to its medical advisory board. In addition to serving on the Company's Advisory Board, Dr. Shapiro is assembling the medical advisory board for Organicell. Dr. Shapiro is a world-renowned cardiologist, a leading speaker on age-management medicine, the holder of two US patents, and had a fellowship in cardiovascular disease at Columbia Presbyterian Medical Center in New York.

  • PR Newswire4 months ago

    Organicell Regenerative Medicine Inc., Biotech Products Services and Research, Inc. Update for Shareholders

    BOCA RATON, Fla., Jan. 30, 2019 /PRNewswire/ -- Biotech Products Services and Research, Inc. operating as Organicell Regenerative Medicine Inc. (BPSR), today is providing its shareholders with an update on the Company's progress. As previously announced, on April 23, 2018, Management and Business Associates, LLC, a company controlled by Mr. Manuel Iglesias, acquired 51% of the Company and Mr. Iglesias became our Chief Executive Officer. Mr. Iglesias brings extensive industry experience and relationships to the Company.

  • We're sorry this is all we were able to find about this topic.